Skip to main content
. 2022 Dec 9;5:1355. doi: 10.1038/s42003-022-04262-3

Table 2.

Pathways of circRNAs degradation.

Degradation pathways Location Interacting molecule Related disease Reference number
Endonuclease-mediated degradation Nuclear/cytoplasm

RNase H1, Template DNA strand

/ RNase L, PKR

Systemic lupus erythematosus 29,33
Ago2-mediated degradation Nuclear miRNA, Ago2

Chronic inflammatory

pain

3537
GW182-mediated degradation \ GW182 \ 38
m6A modification-mediated degradation Cytoplasm YTHDF2, HRSP12, RNase-P/MRP Hepatocellular carcinoma 4042
Structure-mediated degradation Cytoplasm G3BP1, UPF1 \ 43
TMAO-mediated degradation Cytoplasm TMAO Dysbacteriosis in gut 45
Exosome-mediated degradation Extracellular space exosomes/ microvesicles \ 48